DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the launch of PERCLOT Absorbable Hemostatic Powder in the U.S.
New Jersey, N.J., May 17, 2022 Topical Absorbable Hemostat Market report focused on the comprehensive analysis of current and future prospects of the Topical Absorbable Hemostat industry. It describes ...
Surgicel Powder Absorbable Hemostat is a powdered adjunctive hemostat used to control disruptive bleeding. Ethicon announced the launch of Surgicel Powder Absorbable Hemostat (oxidized regenerated ...
SOMERVILLE, N.J., June 6, 2017 /PRNewswire/ -- Uncontrolled bleeding during surgery can adversely affect patient outcomes, hospital costs and resources. 1-9 Primary methods of hemostasis alone may be ...
April 2, 2004 — The U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) issued a Public Health Notification today reminding physicians that a serious adverse ...
COLLEGE PARK, Md., Jan. 12, 2023 /PRNewswire/ -- Medcura, Inc., a medical device company dedicated to transformatively improving the management of surgical bleeding, announces that the U.S. Food and ...
(Nanowerk News) Scientists at Texas A&M University are harnessing the combined power of organic nanomaterials-based chemistry and a natural product found in crustacean exoskeletons to help bring ...
The global hemostats market is projected to reach a value of $2.7 billion by 2025 and is expected to experience a robust growth rate of 6% by 2030. Key factors fueling this expansion include an ...
Marks first passive hemostat for Baxter in the U.S. market, broadening portfolio offering to include a full range of active and passive hemostatic products PERCLOT further enhances clinicians’ ability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback